MUSICK JAMES R enters VITRO BIOPHARMA, INC. with 28.02M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Indirect Derivatives
Filed: 11/14/2022ACC: 0001493152-22-031875
DirectorOfficer10% Owner· Chief Science Officer
Since Nov 2022
28.02M
Baseline shares
8% direct
2.34M
Direct ownership
1 position
5.30M
Derivative underlying
2 instruments
3
Security positions
25.68M indirect
Non-Derivative Holdings3
Common Stock
IndirectShares owned2.96M
Common Stock
DirectShares owned2.34M
Common Stock
IndirectShares owned22.73M
Total
2.34M direct·25.68M indirect28.02M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.96M | Indirect |
| Common Stock | 2.34M | Direct |
| Common Stock | 22.73M | Indirect |
| Total | 28.02M | 2.34M direct·25.68M indirect |
Derivative Holdings2
Employee Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
4.30M
Shares owned
N/A
Exercise price
0.05
Expiration
—
Exercise window
—
Employee Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
1M
Shares owned
N/A
Exercise price
0.50
Expiration
—
Exercise window
—
Total
Underlying
5.30M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock | 0.05 | — | — | 4.30M | N/A |
| Employee Stock Option (Right to Buy) Direct | Common Stock | 0.50 | — | — | 1M | N/A |
| Total | 5.30M | 0.00 | ||||